<?xml version="1.0" encoding="UTF-8"?>
<ref id="B28-vaccines-08-00273">
 <label>28.</label>
 <element-citation publication-type="book">
  <person-group person-group-type="author">
   <name>
    <surname>Weaver</surname>
    <given-names>S.C.</given-names>
   </name>
   <name>
    <surname>Paessler</surname>
    <given-names>S.</given-names>
   </name>
  </person-group>
  <article-title>Chapter 21â€”Alphaviral encephalitides</article-title>
  <source>Vaccines for Biodefense and Emerging and Neglected Diseases</source>
  <person-group person-group-type="editor">
   <name>
    <surname>Barrett</surname>
    <given-names>A.D.T.</given-names>
   </name>
   <name>
    <surname>Stanberry</surname>
    <given-names>L.R.</given-names>
   </name>
  </person-group>
  <publisher-name>Academic Press</publisher-name>
  <publisher-loc>Amsterdam, The Netherlands</publisher-loc>
  <year>2009</year>
  <fpage>339</fpage>
  <lpage>359</lpage>
 </element-citation>
</ref>
